Cancer
ROCHESTER, Minn. — A new study published by Mayo Clinic researchers suggests that ovarian cancer cells quickly activate a survival response after PARP inhibitor treatment,[...]
Latest stories
Research
January 23, 2025
Gastroenterology
January 20, 2025
AI and Digital Health
January 14, 2025
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community